CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 12949-13212 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T77","span":{"begin":0,"end":263},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"47, 48 In the setting of ultra-hypofractionation with 5-fraction regimens, it is reasonable to consider a single 5.2Gy dose to the tumor bed (personal correspondence), although this fractional boost dose remains to be reported beyond the brachytherapy literature."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T77","span":{"begin":0,"end":263},"obj":"Sentence"}],"text":"47, 48 In the setting of ultra-hypofractionation with 5-fraction regimens, it is reasonable to consider a single 5.2Gy dose to the tumor bed (personal correspondence), although this fractional boost dose remains to be reported beyond the brachytherapy literature."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T26","span":{"begin":131,"end":136},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"47, 48 In the setting of ultra-hypofractionation with 5-fraction regimens, it is reasonable to consider a single 5.2Gy dose to the tumor bed (personal correspondence), although this fractional boost dose remains to be reported beyond the brachytherapy literature."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T69","span":{"begin":131,"end":136},"obj":"Disease"},{"id":"T6389","span":{"begin":131,"end":136},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A71038","pred":"mondo_id","subj":"T6389","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"47, 48 In the setting of ultra-hypofractionation with 5-fraction regimens, it is reasonable to consider a single 5.2Gy dose to the tumor bed (personal correspondence), although this fractional boost dose remains to be reported beyond the brachytherapy literature."}